{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:37:21Z","timestamp":1793036241682,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11033-022-07695-5","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T14:33:46Z","timestamp":1656167626000},"page":"10689-10702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The immune system\u2019s role in PCOS"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2800-8437","authenticated-orcid":false,"given":"Maryam","family":"Shamsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4219-9594","authenticated-orcid":false,"given":"Ali","family":"Ghazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4137-8419","authenticated-orcid":false,"given":"Amir Mohammad","family":"Saeedifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3877-0783","authenticated-orcid":false,"given":"Ghasem","family":"Mosayebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5370-0324","authenticated-orcid":false,"given":"Sana Khajeh","family":"pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2632-9889","authenticated-orcid":false,"given":"Ali","family":"Ganji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"key":"7695_CR1","doi-asserted-by":"crossref","unstructured":"Zhang J, Li J, Yan J (2021) Introduction of Female Reproductive Processes and Reproductive Diseases. In: Advances in Experimental Medicine and Biology. pp\u00a023\u201338","DOI":"10.1007\/978-981-33-4187-6_2"},{"key":"7695_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"BCJM Fauser","year":"2004","unstructured":"Fauser BCJM (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"7695_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9061831","volume":"9","author":"E Khashchenko","year":"2020","unstructured":"Khashchenko E, Uvarova E, Vysokikh M et al (2020) The relevant hormonal levels and diagnostic features of polycystic ovary syndrome in adolescents. J Clin Med 9:1\u201312. https:\/\/doi.org\/10.3390\/jcm9061831","journal-title":"J Clin Med"},{"key":"7695_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bpobgyn.2016.03.005","volume":"37","author":"NE Baskind","year":"2016","unstructured":"Baskind NE, Balen AH (2016) Hypothalamic\u2013pituitary, ovarian and adrenal contributions to polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 37:80\u201397","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"7695_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1365-2605.2005.00623.x","volume":"29","author":"S Franks","year":"2006","unstructured":"Franks S, McCarthy MI, Hardy K et al (2006) Development of polycystic ovary syndrome: Involvement of genetic and environmental factors. Int J Androl 29:278\u2013285. https:\/\/doi.org\/10.1111\/j.1365-2605.2005.00623.x","journal-title":"Int J Androl"},{"key":"7695_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/JIR.S260770","volume":"13","author":"S He","year":"2020","unstructured":"He S, Mao X, Lei H et al (2020) Peripheral blood inflammatory-immune cells as a predictor of infertility in women with polycystic ovary syndrome. J Inflamm Res 13:441\u2013450. https:\/\/doi.org\/10.2147\/JIR.S260770","journal-title":"J Inflamm Res"},{"key":"7695_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/09513590.2017.1418851","volume":"34","author":"NJ Su","year":"2018","unstructured":"Su NJ, Ma J, Feng DF et al (2018) The peripheral blood transcriptome identifies dysregulation of inflammatory response genes in polycystic ovary syndrome. Gynecol Endocrinol 34:584\u2013588. https:\/\/doi.org\/10.1080\/09513590.2017.1418851","journal-title":"Gynecol Endocrinol"},{"key":"7695_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.yhbeh.2012.06.005","volume":"62","author":"SD Bilbo","year":"2012","unstructured":"Bilbo SD, Klein SL (2012) Special Issue: The neuroendocrine-immune axis in health and disease. Horm Behav 62:187\u2013190","journal-title":"Horm Behav"},{"key":"7695_CR9","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1210\/jc.2005-0622","volume":"90","author":"M Urbanek","year":"2005","unstructured":"Urbanek M, Woodroffe A, Ewens KG et al (2005) Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab 90:6623\u20136629. https:\/\/doi.org\/10.1210\/jc.2005-0622","journal-title":"J Clin Endocrinol Metab"},{"key":"7695_CR10","doi-asserted-by":"publisher","unstructured":"Zhang T, Tian F, Huo R et al (2017) Detection of dendritic cells and related cytokines in follicular fluid of patients with polycystic ovary syndrome. Am J Reprod Immunol 78. https:\/\/doi.org\/10.1111\/aji.12717","DOI":"10.1111\/aji.12717"},{"key":"7695_CR11","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.intimp.2011.04.024","volume":"11","author":"Z Yang","year":"2011","unstructured":"Yang Z, Kong B, Mosser DM, Zhang X (2011) TLRs, macrophages, and NK cells: Our understandings of their functions in uterus and ovary. Int Immunopharmacol 11:1442\u20131450. https:\/\/doi.org\/10.1016\/j.intimp.2011.04.024","journal-title":"Int Immunopharmacol"},{"key":"7695_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.metabol.2017.02.012","volume":"71","author":"C Ba\u00f1uls","year":"2017","unstructured":"Ba\u00f1uls C, Rovira-Llopis S, Martinez de Mara\u00f1on A et al (2017) Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte\u2013endothelium interactions in PCOS. Metabolism 71:153\u2013162. https:\/\/doi.org\/10.1016\/j.metabol.2017.02.012","journal-title":"Metabolism"},{"key":"7695_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.immuni.2014.04.016","volume":"40","author":"A Mildner","year":"2014","unstructured":"Mildner A, Jung S (2014) Development and function of dendritic cell subsets. Immunity 40:642\u2013656","journal-title":"Immunity"},{"key":"7695_CR14","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.2337\/db11-1274","volume":"61","author":"A Bertola","year":"2012","unstructured":"Bertola A, Ciucci T, Rousseau D et al (2012) Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 61:2238\u20132247. https:\/\/doi.org\/10.2337\/db11-1274","journal-title":"Diabetes"},{"key":"7695_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.fertnstert.2011.12.030","volume":"97","author":"O Fainaru","year":"2012","unstructured":"Fainaru O, Hantisteanu S, Rotfarb N et al (2012) CD11c + HLADR + dendritic cells are present in human ovarian follicular fluid, and their maturity correlates with serum estradiol levels in response to gonadotropins. Fertil Steril 97:702\u2013706. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.12.030","journal-title":"Fertil Steril"},{"key":"7695_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ni.3094","volume":"16","author":"ML Robinette","year":"2015","unstructured":"Robinette ML, Fuchs A, Cortez VS et al (2015) Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol 16:306\u2013317. https:\/\/doi.org\/10.1038\/ni.3094","journal-title":"Nat Immunol"},{"key":"7695_CR17","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.4049\/jimmunol.1301176","volume":"191","author":"E Hams","year":"2013","unstructured":"Hams E, Locksley RM, McKenzie ANJ, Fallon PG (2013) Cutting Edge: IL-25 Elicits Innate Lymphoid Type 2 and Type II NKT Cells That Regulate Obesity in Mice. J Immunol 191:5349\u20135353. https:\/\/doi.org\/10.4049\/jimmunol.1301176","journal-title":"J Immunol"},{"key":"7695_CR18","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1210\/jc.2017-02799","volume":"103","author":"M Insenser","year":"2018","unstructured":"Insenser M, Murri M, Del Campo R et al (2018) Gut microbiota and the polycystic ovary syndrome: Influence of sex, sex hormones, and obesity. J Clin Endocrinol Metab 103:2552\u20132562. https:\/\/doi.org\/10.1210\/jc.2017-02799","journal-title":"J Clin Endocrinol Metab"},{"key":"7695_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi X, Yun C, Sun L et al (2019) Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med 25:1225\u20131233. https:\/\/doi.org\/10.1038\/s41591-019-0509-0","journal-title":"Nat Med"},{"key":"7695_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria A, Madrigal JA, Saudemont A (2017) B cell regulation in cancer and anti-tumor immunity. Cell Mol Immunol 14:662\u2013674","journal-title":"Cell Mol Immunol"},{"key":"7695_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9782373","author":"Q Xie","year":"2019","unstructured":"Xie Q, Xiong X, Xiao N et al (2019) Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice. Stem Cells Int 2019:. https:\/\/doi.org\/10.1155\/2019\/9782373","journal-title":"Stem Cells Int 2019:"},{"key":"7695_CR22","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.fertnstert.2009.01.056","volume":"93","author":"K Hefler-Frischmuth","year":"2010","unstructured":"Hefler-Frischmuth K, Walch K, Huebl W et al (2010) Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril 93:2291\u20132294. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.01.056","journal-title":"Fertil Steril"},{"key":"7695_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF01891775","volume":"7","author":"SF Schlossman","year":"1984","unstructured":"Schlossman SF, Reinherz EL (1984) Human T-cell subsets in health and disease. Springer Semin Immunopathol 7:9\u201318. https:\/\/doi.org\/10.1007\/BF01891775","journal-title":"Springer Semin Immunopathol"},{"key":"7695_CR24","doi-asserted-by":"publisher","unstructured":"Li Z, Peng A, Feng Y et al (2019) Detection of T lymphocyte subsets and related functional molecules in follicular fluid of patients with polycystic ovary syndrome. Sci Rep 9. https:\/\/doi.org\/10.1038\/s41598-019-42631-x","DOI":"10.1038\/s41598-019-42631-x"},{"key":"7695_CR25","doi-asserted-by":"crossref","unstructured":"Gagliani N, Huber S (2017) Basic aspects of T helper cell differentiation. In: Methods in Molecular Biology. pp\u00a019\u201330","DOI":"10.1007\/978-1-4939-6548-9_2"},{"key":"7695_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.fsi.2019.01.016","volume":"87","author":"XH Song","year":"2019","unstructured":"Song XH, Tang J, Gao TT et al (2019) Interleukin-12 receptor \u03b22 from grass carp: Molecular characterization and its involvement in Aeromonas hydrophila-induced intestinal inflammation. Fish Shellfish Immunol 87:226\u2013234. https:\/\/doi.org\/10.1016\/j.fsi.2019.01.016","journal-title":"Fish Shellfish Immunol"},{"key":"7695_CR27","doi-asserted-by":"publisher","unstructured":"Lee HL, Jang JW, Lee SW et al (2019) Inflammatory cytokines and change of Th1\/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization. Sci Rep 9. https:\/\/doi.org\/10.1038\/s41598-019-40078-8","DOI":"10.1038\/s41598-019-40078-8"},{"key":"7695_CR28","doi-asserted-by":"crossref","unstructured":"Cutolo M, Sulli A, Capellino S et al (2004) Sex hormones influence on the immune system: Basic and clinical aspects in autoimmunity. In: Lupus. pp\u00a0635\u2013638","DOI":"10.1191\/0961203304lu1094oa"},{"key":"7695_CR29","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0015-0282(03)00344-3","volume":"79","author":"A Gallinelli","year":"2003","unstructured":"Gallinelli A, Ciaccio I, Giannella L et al (2003) Correlations between concentrations of interleukin-12 and interleukin-13 and lymphocyte subsets in the follicular fluid of women with and without polycystic ovary syndrome. Fertil Steril 79:1365\u20131372. https:\/\/doi.org\/10.1016\/S0015-0282(03)00344-3","journal-title":"Fertil Steril"},{"key":"7695_CR30","first-page":"175","volume":"15","author":"F Nasri","year":"2018","unstructured":"Nasri F, Doroudchi M, Jahromi BN, Gharesi-Fard B (2018) T helper cells profile and cd4 + cd25 + foxp3 + regulatory t cells in polycystic ovary syndrome. Iran J Immunol 15:175\u2013185","journal-title":"Iran J Immunol"},{"key":"7695_CR31","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.fertnstert.2011.01.129","volume":"95","author":"G Niccoli","year":"2011","unstructured":"Niccoli G, Apa R, Lanzone A et al (2011) CD4 + CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome. Fertil Steril 95:2651\u20132654. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.01.129","journal-title":"Fertil Steril"},{"key":"7695_CR32","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"Liu W, Putnam AL, Xu-yu Z et al (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + T reg cells. J Exp Med 203:1701\u20131711. https:\/\/doi.org\/10.1084\/jem.20060772","journal-title":"J Exp Med"},{"key":"7695_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1210\/en.2015-1313","volume":"157","author":"P Gourdy","year":"2016","unstructured":"Gourdy P, Bourgeois EA, Levescot A et al (2016) Estrogen therapy delays autoimmune diabetes and promotes the protective efficiency of natural killer T-cell activation in female non-obese diabetic mice. Endocrinology 157:258\u2013267. https:\/\/doi.org\/10.1210\/en.2015-1313","journal-title":"Endocrinology"},{"key":"7695_CR34","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1091\/mbc.E14-08-1323","volume":"26","author":"M Walecki","year":"2015","unstructured":"Walecki M, Eisel F, Klug J et al (2015) Androgen receptor modulates Foxp3 expression in CD4 + CD25 + Foxp3 + regulatory T-cells. Mol Biol Cell 26:2845\u20132857. https:\/\/doi.org\/10.1091\/mbc.E14-08-1323","journal-title":"Mol Biol Cell"},{"key":"7695_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/jc.2014-2401","volume":"100","author":"MB Krishna","year":"2015","unstructured":"Krishna MB, Joseph A, Subramaniam AG et al (2015) Reduced tregs in peripheral blood of PCOS patients - A consequence of aberrant Il2 signaling. J Clin Endocrinol Metab 100:282\u2013292. https:\/\/doi.org\/10.1210\/jc.2014-2401","journal-title":"J Clin Endocrinol Metab"},{"key":"7695_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1365-2567.2004.01869.x","volume":"112","author":"DA Somerset","year":"2004","unstructured":"Somerset DA, Zheng Y, Kilby MD et al (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25 + CD4 + regulatory T-cell subset. Immunology 112:38\u201343. https:\/\/doi.org\/10.1111\/j.1365-2567.2004.01869.x","journal-title":"Immunology"},{"key":"7695_CR37","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3109\/09513590.2012.683082","volume":"28","author":"E Deligeoroglou","year":"2012","unstructured":"Deligeoroglou E, Vrachnis N, Athanasopoulos N et al (2012) Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol Endocrinol 28:974\u2013978. https:\/\/doi.org\/10.3109\/09513590.2012.683082","journal-title":"Gynecol Endocrinol"},{"key":"7695_CR38","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3109\/09513590.2012.760195","volume":"29","author":"K Ebejer","year":"2013","unstructured":"Ebejer K, Calleja-Agius J (2013) The role of cytokines in polycystic ovarian syndrome. Gynecol Endocrinol 29:536\u2013540. https:\/\/doi.org\/10.3109\/09513590.2012.760195","journal-title":"Gynecol Endocrinol"},{"key":"7695_CR39","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/oxfordjournals.humrep.a137929","volume":"8","author":"M Br\u00e4nnstr\u00f6m","year":"1993","unstructured":"Br\u00e4nnstr\u00f6m M, Norman RJ (1993) Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 8:1762\u20131775. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a137929","journal-title":"Hum Reprod"},{"key":"7695_CR40","doi-asserted-by":"publisher","first-page":"21839","DOI":"10.1016\/s0021-9258(18)54714-1","volume":"266","author":"JM Stephens","year":"1991","unstructured":"Stephens JM, Pekala PH (1991) Transcriptional repression of the GLUT4 and C\/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-\u03b1. J Biol Chem 266:21839\u201321845. https:\/\/doi.org\/10.1016\/s0021-9258(18)54714-1","journal-title":"J Biol Chem"},{"key":"7695_CR41","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1095\/biolreprod61.4.993","volume":"61","author":"RZ Spaczynski","year":"1999","unstructured":"Spaczynski RZ, Arici A, Duleba AJ (1999) Tumor necrosis factor-\u03b1 stimulates proliferation of rat ovarian theca- interstitial cells. Biol Reprod 61:993\u2013998. https:\/\/doi.org\/10.1095\/biolreprod61.4.993","journal-title":"Biol Reprod"},{"key":"7695_CR42","first-page":"165","volume":"48","author":"NC Sayin","year":"2003","unstructured":"Sayin NC, G\u00fccer F, Balkanli-Kaplan P et al (2003) Elevated serum TNF-\u03b1 levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome. J Reprod Med Obstet Gynecol 48:165\u2013170","journal-title":"J Reprod Med Obstet Gynecol"},{"key":"7695_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4049\/jimmunol.1400381","volume":"193","author":"CI Carlock","year":"2014","unstructured":"Carlock CI, Wu J, Zhou C et al (2014) Unique Temporal and Spatial Expression Patterns of IL-33 in Ovaries during Ovulation and Estrous Cycle Are Associated with Ovarian Tissue Homeostasis. J Immunol 193:161\u2013169. https:\/\/doi.org\/10.4049\/jimmunol.1400381","journal-title":"J Immunol"},{"key":"7695_CR44","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s40618-016-0472-2","volume":"39","author":"M Karakose","year":"2016","unstructured":"Karakose M, Demircan K, Tutal E et al (2016) Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome. J Endocrinol Invest 39:1269\u20131275. https:\/\/doi.org\/10.1007\/s40618-016-0472-2","journal-title":"J Endocrinol Invest"},{"key":"7695_CR45","doi-asserted-by":"publisher","unstructured":"Mazloomi S, Sheikh N, Sanoee Farimani M, Pilehvari S (2021) Association of Prx4, Total Oxidant Status, and Inflammatory Factors with Insulin Resistance in Polycystic Ovary Syndrome. Int J Endocrinol 2021:. https:\/\/doi.org\/10.1155\/2021\/9949753","DOI":"10.1155\/2021\/9949753"},{"key":"7695_CR46","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","volume":"86","author":"CCJ Kelly","year":"2001","unstructured":"Kelly CCJ, Lyall H, Petrie JR et al (2001) Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 86:2453\u20132455. https:\/\/doi.org\/10.1210\/jcem.86.6.7580","journal-title":"J Clin Endocrinol Metab"},{"key":"7695_CR47","doi-asserted-by":"publisher","unstructured":"Escobar-Morreale HF, Luque-Ram\u00edrez M, Gonz\u00e1lez F (2011) Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis. Fertil Steril 95. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.11.036","DOI":"10.1016\/j.fertnstert.2010.11.036"},{"key":"7695_CR48","doi-asserted-by":"publisher","unstructured":"Haidari F, Banaei-Jahromi N, Zakerkish M, Ahmadi K (2020) The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: A randomized open-labeled controlled clinical trial. Nutr J 19. https:\/\/doi.org\/10.1186\/s12937-020-0524-5","DOI":"10.1186\/s12937-020-0524-5"},{"key":"7695_CR49","doi-asserted-by":"publisher","first-page":"10794","DOI":"10.1158\/0008-5472.CAN-05-0623","volume":"65","author":"MB Nilsson","year":"2005","unstructured":"Nilsson MB, Langley RR, Fidler IJ (2005) Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 65:10794\u201310800. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0623","journal-title":"Cancer Res"},{"key":"7695_CR50","doi-asserted-by":"crossref","unstructured":"Deshpande RR, Chang MDY, Chapman JC, Michael SD (2000) Alteration of cytokine production in follicular cystic ovaries induced in mice by neonatal estradiol injection. In: American Journal of Reproductive Immunology. pp\u00a080\u201388","DOI":"10.1111\/j.8755-8920.2000.440203.x"},{"key":"7695_CR51","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.12659\/MSM.916385","volume":"25","author":"Z Zhuang","year":"2019","unstructured":"Zhuang Z, Pan X, Zhao K et al (2019) The effect of Interleukin-6 (IL-6), Interleukin-11 (IL-11), Signal Transducer and Activator of Transcription 3 (STAT3), and AKT signaling on adipocyte proliferation in a rat model of polycystic ovary syndrome. Med Sci Monit 25:7218\u20137227. https:\/\/doi.org\/10.12659\/MSM.916385","journal-title":"Med Sci Monit"},{"key":"7695_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/09513590.2012.730581","volume":"29","author":"E Rey-Roldan","year":"2013","unstructured":"Rey-Roldan E, Lana MBP, Galluzzo L et al (2013) Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk? Gynecol Endocrinol 29:141\u2013144. https:\/\/doi.org\/10.3109\/09513590.2012.730581","journal-title":"Gynecol Endocrinol"},{"key":"7695_CR53","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/cen.12003","volume":"77","author":"A Lansdown","year":"2012","unstructured":"Lansdown A, Rees DA (2012) The sympathetic nervous system in polycystic ovary syndrome: A novel therapeutic target? Clin. Endocrinol (Oxf) 77:791\u2013801","journal-title":"Endocrinol (Oxf)"},{"key":"7695_CR54","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1093\/oxfordjournals.humrep.a135889","volume":"10","author":"CL Best","year":"1995","unstructured":"Best CL, Hill JA (1995) Interleukin-1\u03b1 and -\u03b2 modulation of luteinized human granulosa cell oestrogen and progesterone biosynthesis. Hum Reprod 10:3206\u20133210. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a135889","journal-title":"Hum Reprod"},{"key":"7695_CR55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.29252\/ijrm.15.6.375","volume":"15","author":"FZ Zangeneh","year":"2017","unstructured":"Zangeneh FZ, Naghizadeh MM, Masoumi M (2017) Polycystic ovary syndrome and circulating inflammatory markers. Int J Reprod Biomed 15:375\u2013382. https:\/\/doi.org\/10.29252\/ijrm.15.6.375","journal-title":"Int J Reprod Biomed"},{"key":"7695_CR56","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1210\/jc.2005-2327","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP (2006) Increased activation of nuclear factor \u03baB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab 91:1508\u20131512. https:\/\/doi.org\/10.1210\/jc.2005-2327","journal-title":"J Clin Endocrinol Metab"},{"key":"7695_CR57","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","volume":"178","author":"A D\u2019andrea","year":"1993","unstructured":"D\u2019andrea A, Aste-Amezaga M, Valiante NM et al (1993) Interleukin 10 (IL-10) Inhibits human lymphocyte interferon \u03b3-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells. J Exp Med 178:1041\u20131048. https:\/\/doi.org\/10.1084\/jem.178.3.1041","journal-title":"J Exp Med"},{"key":"7695_CR58","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.mgene.2016.08.001","volume":"9","author":"RM Talaat","year":"2016","unstructured":"Talaat RM, Mohamed YA, Mohamad EH et al (2016) Interleukin 10 (\u2013 1082 G\/A) and (\u2013 819\u00a0C\/T) gene polymorphisms in Egyptian women with polycystic ovary syndrome (PCOS). Meta Gene 9:254\u2013258. https:\/\/doi.org\/10.1016\/j.mgene.2016.08.001","journal-title":"Meta Gene"},{"key":"7695_CR59","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2337\/db06-0047","volume":"55","author":"D Scarpelli","year":"2006","unstructured":"Scarpelli D, Cardellini M, Andreozzi F et al (2006) Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 55:1529\u20131533. https:\/\/doi.org\/10.2337\/db06-0047","journal-title":"Diabetes"},{"key":"7695_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10555-006-9013-3","volume":"25","author":"F Vidal-Vanaclocha","year":"2006","unstructured":"Vidal-Vanaclocha F, Mendoza L, Telleria N et al (2006) Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev 25:417\u2013434","journal-title":"Cancer Metastasis Rev"},{"key":"7695_CR61","doi-asserted-by":"publisher","unstructured":"Rostamtabar M, Esmaeilzadeh S, Karkhah A et al (2020) Elevated expression of IL-18 but not IL-1\u03b2 gene is associated with NALP3 and AIM2 inflammasome in Polycystic Ovary Syndrome. https:\/\/doi.org\/10.1016\/j.gene.2020.144352. Gene 731:","DOI":"10.1016\/j.gene.2020.144352"},{"key":"7695_CR62","doi-asserted-by":"publisher","unstructured":"Zhang H, Wang X, Xu J et al (2020) IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with unexplained infertility to PCOS during in vitro fertilization. J Reprod Immunol 138. https:\/\/doi.org\/10.1016\/j.jri.2020.103083","DOI":"10.1016\/j.jri.2020.103083"},{"key":"7695_CR63","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1210\/endo.137.9.8756544","volume":"137","author":"A Arici","year":"1996","unstructured":"Arici A, Oral E, Bukulmez O et al (1996) Interleukin-8 expression and modulation in human preovulatory follicles and ovarian cells. Endocrinology 137:3762\u20133769. https:\/\/doi.org\/10.1210\/endo.137.9.8756544","journal-title":"Endocrinology"},{"key":"7695_CR64","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1055\/a-1018-9606","volume":"51","author":"DES Ali","year":"2019","unstructured":"Ali DES, Shah M, Ali A et al (2019) Treatment with Metformin and Combination of Metformin plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial. Horm Metab Res 51:714\u2013722. https:\/\/doi.org\/10.1055\/a-1018-9606","journal-title":"Horm Metab Res"},{"key":"7695_CR65","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1902\/jop.2013.120483","volume":"84","author":"\u00d6 \u00d6z\u00e7aka","year":"2013","unstructured":"\u00d6z\u00e7aka \u00d6, Buduneli N, Ceyhan BO et al (2013) Is Interleukin-17 Involved in the Interaction Between Polycystic Ovary Syndrome and Gingival Inflammation? J Periodontol 84:1827\u20131837. https:\/\/doi.org\/10.1902\/jop.2013.120483","journal-title":"J Periodontol"},{"key":"7695_CR66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.18502\/ijaai.v18i1.634","volume":"18","author":"F Hesampour","year":"2019","unstructured":"Hesampour F, Jahromi BN, Tahmasebi F, Gharesi-Fard B (2019) Association between interleukin-32 and interleukin-17a single nucleotide polymorphisms and serum levels with polycystic ovary syndrome. Iran J Allergy Asthma Immunol 18:91\u201399. https:\/\/doi.org\/10.18502\/ijaai.v18i1.634","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"7695_CR67","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0165-0378(97)82476-X","volume":"32","author":"A Arici","year":"1997","unstructured":"Arici A, Oral E, Bukulmez O et al (1997) Monocyte chemotactic protein-1 expression in human preovulatory follicles and ovarian cells. J Reprod Immunol 32:201\u2013219. https:\/\/doi.org\/10.1016\/S0165-0378(97)82476-X","journal-title":"J Reprod Immunol"},{"key":"7695_CR68","doi-asserted-by":"publisher","unstructured":"Wu Z, Fang L, Li Y et al (2021) Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: A meta-analysis. Am J Reprod Immunol 86. https:\/\/doi.org\/10.1111\/aji.13407","DOI":"10.1111\/aji.13407"},{"key":"7695_CR69","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1365-2265.2009.03523.x","volume":"71","author":"D Glintborg","year":"2009","unstructured":"Glintborg D, Andersen M, Richelsen B, Bruun JM (2009) Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1\u03b1 are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment. Clin Endocrinol (Oxf) 71:652\u2013658. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03523.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7695_CR70","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1073\/pnas.012511599","volume":"99","author":"RA Mitchell","year":"2002","unstructured":"Mitchell RA, Liao H, Chesney J et al (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage pro-inflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proc Natl Acad Sci U S A 99:345\u2013350. https:\/\/doi.org\/10.1073\/pnas.012511599","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7695_CR71","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1023\/A:1021219317155","volume":"19","author":"T Matsuura","year":"2002","unstructured":"Matsuura T, Sugimura M, Iwaki T et al (2002) Anti-macrophage inhibitory factor antibody inhibits PMSG-hCG-induced follicular growth and ovulation in mice. J Assist Reprod Genet 19:591\u2013595. https:\/\/doi.org\/10.1023\/A:1021219317155","journal-title":"J Assist Reprod Genet"},{"key":"7695_CR72","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/jmbi.1998.1864","volume":"280","author":"R Kleemann","year":"1998","unstructured":"Kleemann R, Kapurniotu A, Frank RW et al (1998) Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol 280:85\u2013102. https:\/\/doi.org\/10.1006\/jmbi.1998.1864","journal-title":"J Mol Biol"},{"key":"7695_CR73","doi-asserted-by":"publisher","unstructured":"He Z, Wang Y, Zhuan L et al (2021) MIF-mediated NF-\u03baB signaling pathway regulates the pathogenesis of polycystic ovary syndrome in rats. Cytokine 146. https:\/\/doi.org\/10.1016\/j.cyto.2021.155632","DOI":"10.1016\/j.cyto.2021.155632"},{"key":"7695_CR74","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/07435800.2015.1135442","volume":"41","author":"M Calan","year":"2016","unstructured":"Calan M, Kume T, Yilmaz O et al (2016) A possible link between luteinizing hormone and macrophage migration inhibitory factor levels in polycystic ovary syndrome. Endocr Res 41:261\u2013269. https:\/\/doi.org\/10.3109\/07435800.2015.1135442","journal-title":"Endocr Res"},{"key":"7695_CR75","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1093\/humrep\/14.12.2944","volume":"14","author":"E Somigliana","year":"1999","unstructured":"Somigliana E, Vigan\u00f2 P, Rossi G et al (1999) Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum Reprod 14:2944\u20132950. https:\/\/doi.org\/10.1093\/humrep\/14.12.2944","journal-title":"Hum Reprod"},{"key":"7695_CR76","doi-asserted-by":"crossref","unstructured":"Coskun S, Uzumcu M, Jaroudi K et al (1998) Presence of leukemia inhibitory factor and interleukin-12 in human follicular fluid during follicular growth. In: American Journal of Reproductive Immunology. pp\u00a013\u201318","DOI":"10.1111\/j.1600-0897.1998.tb00382.x"},{"key":"7695_CR77","doi-asserted-by":"publisher","unstructured":"Lin K, Sun X, Wang X et al (2021) Circulating Adipokine Levels in Nonobese Women With Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 11. https:\/\/doi.org\/10.3389\/fendo.2020.537809","DOI":"10.3389\/fendo.2020.537809"},{"key":"7695_CR78","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09513590.2018.1534096","volume":"35","author":"DP Baldani","year":"2019","unstructured":"Baldani DP, Skrgatic L, Kasum M et al (2019) Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality. Gynecol Endocrinol 35:401\u2013405. https:\/\/doi.org\/10.1080\/09513590.2018.1534096","journal-title":"Gynecol Endocrinol"},{"key":"7695_CR79","doi-asserted-by":"crossref","unstructured":"Zhang Y, Proenca R, Maffei M et al (1994) Positional cloning of the mouse obese gene and its human homologue","DOI":"10.1038\/372425a0"},{"key":"7695_CR80","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/1933719116670265","volume":"24","author":"SH Zheng","year":"2017","unstructured":"Zheng SH, Du DF, Li XL (2017) Leptin Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis. Reprod Sci 24:656\u2013670","journal-title":"Reprod Sci"},{"key":"7695_CR81","doi-asserted-by":"publisher","unstructured":"Barrea L, Arnone A, Annunziata G et al (2019) Adherence to the mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). https:\/\/doi.org\/10.3390\/nu11102278. Nutrients 11:","DOI":"10.3390\/nu11102278"},{"key":"7695_CR82","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/CS20070196","volume":"114","author":"H Tilg","year":"2008","unstructured":"Tilg H, Moschen AR (2008) Role of adiponectin and PBEF\/visfatin as regulators of inflammation: Involvement in obesity-associated diseases. Clin Sci 114:275\u2013288","journal-title":"Clin Sci"},{"key":"7695_CR83","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/humupd\/dmp006","volume":"15","author":"KA Toulis","year":"2009","unstructured":"Toulis KA, Goulis DG, Farmakiotis D et al (2009) Adiponectin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis. Hum Reprod Update 15:297\u2013307","journal-title":"Hum Reprod Update"},{"key":"7695_CR84","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/13813455.2018.1518987","volume":"126","author":"DM Bannigida","year":"2020","unstructured":"Bannigida DM, Nayak SB, Vijayaragavan R (2020) Serum visfatin and adiponectin\u2013markers in women with polycystic ovarian syndrome. Arch Physiol Biochem 126:283\u2013286. https:\/\/doi.org\/10.1080\/13813455.2018.1518987","journal-title":"Arch Physiol Biochem"},{"key":"7695_CR85","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.dsx.2020.01.008","volume":"14","author":"K Dogan","year":"2020","unstructured":"Dogan K, Helvacioglu C, Baghaki S, Ekin M (2020) Comparison of body mass index and metabolic parameters with serum vaspin levels in women with polycystic ovary syndrome. Diabetes Metab Syndr Clin Res Rev 14:137\u2013139. https:\/\/doi.org\/10.1016\/j.dsx.2020.01.008","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"7695_CR86","doi-asserted-by":"publisher","first-page":"0","DOI":"10.21608\/zumj.2019.16853.1514","volume":"0","author":"W Ashour","year":"2019","unstructured":"Ashour W, Abdel-Aleem D, Khalil S, Elkazzaz O (2019) Serum Adropin and Vaspin Levels in Obese Rats with Polycystic Ovary Syndrome and After Metformin Treatment. Zagazig Univ Med J 0:0\u20130. https:\/\/doi.org\/10.21608\/zumj.2019.16853.1514","journal-title":"Zagazig Univ Med J"},{"key":"7695_CR87","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2337\/db08-0127","volume":"57","author":"BK Tan","year":"2008","unstructured":"Tan BK, Heutling D, Chen J et al (2008) Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57:1501\u20131507. https:\/\/doi.org\/10.2337\/db08-0127","journal-title":"Diabetes"},{"key":"7695_CR88","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/09513590802653833","volume":"25","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Bukan N, Demirc H et al (2009) Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 25:246\u2013252. https:\/\/doi.org\/10.1080\/09513590802653833","journal-title":"Gynecol Endocrinol"},{"key":"7695_CR89","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Bailey ST, Bhat S et al (2001) The hormone resistin links obesity to diabetes. Nature 409:307\u2013312. https:\/\/doi.org\/10.1038\/35053000","journal-title":"Nature"},{"key":"7695_CR90","doi-asserted-by":"crossref","unstructured":"Raeisi T, Rezaie H, Darand M et al (2021) Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis.PLoS One16","DOI":"10.1371\/journal.pone.0246200"},{"key":"7695_CR91","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1126\/science.1097243","volume":"307","author":"A Fukuhara","year":"2005","unstructured":"Fukuhara A, Matsuda M, Nishizawa M et al (2005) Visfatin: A protein secreted by visceral fat that Mimics the effects of insulin. Sci (80-) 307:426\u2013430. https:\/\/doi.org\/10.1126\/science.1097243","journal-title":"Sci (80-)"},{"key":"7695_CR92","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1365-2362.2011.02586.x","volume":"42","author":"TK Lajunen","year":"2012","unstructured":"Lajunen TK, Purhonen AK, Haapea M et al (2012) Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome. Eur J Clin Invest 42:321\u2013328. https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02586.x","journal-title":"Eur J Clin Invest"},{"key":"7695_CR93","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3109\/09513590.2015.1056140","volume":"31","author":"Y Sun","year":"2015","unstructured":"Sun Y, Wu Z, Wei L et al (2015) High-visfatin levels in women with polycystic ovary syndrome: Evidence from a meta-analysis. Gynecol Endocrinol 31:808\u2013814. https:\/\/doi.org\/10.3109\/09513590.2015.1056140","journal-title":"Gynecol Endocrinol"},{"key":"7695_CR94","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/dmrr.1201","volume":"27","author":"YH Chang","year":"2011","unstructured":"Chang YH, Chang DM, Lin KC et al (2011) Visfatin in overweight\/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: A meta-analysis and systemic review. Diabetes Metab Res Rev 27:515\u2013527","journal-title":"Diabetes Metab Res Rev"},{"key":"7695_CR95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.diabres.2010.01.013","volume":"88","author":"HY Pan","year":"2010","unstructured":"Pan HY, Guo L, Li Q (2010) Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 88:29\u201333. https:\/\/doi.org\/10.1016\/j.diabres.2010.01.013","journal-title":"Diabetes Res Clin Pract"},{"key":"7695_CR96","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clnesp.2020.06.014","volume":"39","author":"A Arab","year":"2020","unstructured":"Arab A, Moosavian SP, Hadi A et al (2020) The association between serum omentin level and bodyweight: A systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 39:22\u201329. https:\/\/doi.org\/10.1016\/j.clnesp.2020.06.014","journal-title":"Clin Nutr ESPEN"},{"key":"7695_CR97","doi-asserted-by":"publisher","first-page":"308","DOI":"10.5603\/GP.2020.0057","volume":"91","author":"G Franik","year":"2020","unstructured":"Franik G, Sadlocha M, Madej P et al (2020) Circulating omentin-1 levels and inflammation in polycystic ovary syndrome. Ginekol Pol 91:308\u2013312. https:\/\/doi.org\/10.5603\/GP.2020.0057","journal-title":"Ginekol Pol"},{"key":"7695_CR98","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ando.2014.04.013","volume":"75","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Zhu L, Zheng M et al (2014) Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults. Ann Endocrinol (Paris) 75:171\u2013175. https:\/\/doi.org\/10.1016\/j.ando.2014.04.013","journal-title":"Ann Endocrinol (Paris)"},{"key":"7695_CR99","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cca.2015.09.015","volume":"450","author":"R Huang","year":"2015","unstructured":"Huang R, Yue J, Sun Y et al (2015) Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume. Clin Chim Acta 450:366\u2013369. https:\/\/doi.org\/10.1016\/j.cca.2015.09.015","journal-title":"Clin Chim Acta"},{"key":"7695_CR100","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.dsx.2019.01.050","volume":"13","author":"AA Foda","year":"2019","unstructured":"Foda AA, Foda EA, El-Negeri MA, El-Said ZH (2019) Serum chemerin levels in Polycystic Ovary Syndrome after metformin therapy. Diabetes Metab Syndr Clin Res Rev 13:1309\u20131315. https:\/\/doi.org\/10.1016\/j.dsx.2019.01.050","journal-title":"Diabetes Metab Syndr Clin Res Rev"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07695-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07695-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07695-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T07:31:35Z","timestamp":1667115095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07695-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7695"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07695-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,25]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This review does not contain any studies with human participants or animals performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}